Companies / BOC Sciences / Spesolimab
BOC Sciences

Spesolimab | BOC Sciences

Spesolimab is a monoclonal antibody that targets interleukin-36 receptor (IL-36R). Spesolimab has been approved for the treatment of generalized pustular psoriasis (GPP) flares in adults.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.